康复新液联合泮托拉唑治疗消化性溃疡的效果及对炎症因子水平的影响
|
摘要
目的观察康复新液联合泮托拉唑治疗消化性溃疡的效果及对炎症因子水平的影响。方法将94例消化性溃疡患者按照随机分配原则分为对照组和观察组,各47例。对照组予以泮托拉唑治疗,观察组在对照组基础上联合康复新液治疗。比较两组患者炎症因子水平及不良反应发生情况。结果治疗后,两组C反应蛋白、肿瘤坏死因子-α及白细胞介素-6水平均降低,且观察组低于对照组(P<0.05)。观察组不良反应总发生率低于对照组(P<0.05)。结论康复新液联合泮托拉唑治疗消化性溃疡的效果显著,可以有效降低炎症因子水平及不良反应发生率,值得临床推广。
Objective To observe the effect of Kangfuxin liquid and pantoprazole in the treatment of peptic ulcer and its influence on inflammatory factors levels. Methods A total of 94 patients with peptic ulcer were divided into control group and observation group according to the principle of random distribution, with 47 cases in each group. The control group was treated with pantoprazole, while the observation group was treated with Kangfuxin liquid on the basis of the control group.The levels of inflammatory factors and adverse reactions were compared between the two groups. Results After treatment,the levels of C-reactive protein, tumor necrosis factor-α and interleukin-6 decreased in both groups, and those in the observation group were lower than the control group(P<0.05). The total incidence of adverse reactions in the observation group was lower than that in the control group(P<0.05). Conclusion Kangfuxin liquid combined with pantoprazole in the treatment of peptic ulcer has a significant effect, which can effectively reduce the levels of inflammatory factors and the incidence of adverse reactions. It is worthy of clinical promotion.
Objective To observe the effect of Kangfuxin liquid and pantoprazole in the treatment of peptic ulcer and its influence on inflammatory factors levels. Methods A total of 94 patients with peptic ulcer were divided into control group and observation group according to the principle of random distribution, with 47 cases in each group. The control group was treated with pantoprazole, while the observation group was treated with Kangfuxin liquid on the basis of the control group.The levels of inflammatory factors and adverse reactions were compared between the two groups. Results After treatment,the levels of C-reactive protein, tumor necrosis factor-α and interleukin-6 decreased in both groups, and those in the observation group were lower than the control group(P<0.05). The total incidence of adverse reactions in the observation group was lower than that in the control group(P<0.05). Conclusion Kangfuxin liquid combined with pantoprazole in the treatment of peptic ulcer has a significant effect, which can effectively reduce the levels of inflammatory factors and the incidence of adverse reactions. It is worthy of clinical promotion.
引文
[1]孙圣秋.康复新液联合泮托拉唑治疗消化性溃疡疗效观察[J].中国冶金工业医学杂志,2018,35(5):515-516.
[2]董志超.康复新液联合泮托拉唑治疗消化性溃疡的效果评估[J].现代诊断与治疗,2018,29(10):1563-1564.
[3]王明会.康复新液联合泮托拉唑用于消化性溃疡治疗的优越性分析[J].中国实用医药,2018,13(10):118-119.
[4]王芳.泮托拉唑联合康复新液治疗消化性溃疡的临床疗效探讨[J].基层医学论坛,2018,22(7):931-932.
[5]谢龙.康复新液联合泮托拉唑对消化性溃疡疾病的治疗价值探析[J].中国实用医药,2017,12(27):108-110.
[6]马晨飞.康复新液联合泮托拉唑三联疗法治疗消化性溃疡的临床疗效[J].临床合理用药杂志,2016,9(21):69-70.
[7]陈光敏.康复新液联合泮托拉唑治疗消化性溃疡临床观察[J].深圳中西医结合杂志,2017,27(7):90-91.
[8]何敏.康复新液与伴托拉唑结合用于消化性溃疡治疗疗效及安全性评价[J].中国社区医师,2016,32(20):100-101.
[9]孙楹.康复新液联合伴托拉唑治疗消化性溃疡的疗效及安全性[J].临床合理用药,2017,10(2):41-42.
[10]张海定,裘亚龙,卓维波.康复新液联合三联疗法治疗幽门螺杆菌相关十二指肠球部溃疡临床研究[J].新中医,2016,8(13):81-83.
[2]董志超.康复新液联合泮托拉唑治疗消化性溃疡的效果评估[J].现代诊断与治疗,2018,29(10):1563-1564.
[3]王明会.康复新液联合泮托拉唑用于消化性溃疡治疗的优越性分析[J].中国实用医药,2018,13(10):118-119.
[4]王芳.泮托拉唑联合康复新液治疗消化性溃疡的临床疗效探讨[J].基层医学论坛,2018,22(7):931-932.
[5]谢龙.康复新液联合泮托拉唑对消化性溃疡疾病的治疗价值探析[J].中国实用医药,2017,12(27):108-110.
[6]马晨飞.康复新液联合泮托拉唑三联疗法治疗消化性溃疡的临床疗效[J].临床合理用药杂志,2016,9(21):69-70.
[7]陈光敏.康复新液联合泮托拉唑治疗消化性溃疡临床观察[J].深圳中西医结合杂志,2017,27(7):90-91.
[8]何敏.康复新液与伴托拉唑结合用于消化性溃疡治疗疗效及安全性评价[J].中国社区医师,2016,32(20):100-101.
[9]孙楹.康复新液联合伴托拉唑治疗消化性溃疡的疗效及安全性[J].临床合理用药,2017,10(2):41-42.
[10]张海定,裘亚龙,卓维波.康复新液联合三联疗法治疗幽门螺杆菌相关十二指肠球部溃疡临床研究[J].新中医,2016,8(13):81-83.